As the end of the year approaches, Bavarian Nordic has started to look towards 2020, and has revealed two central points of next year's work: the purchase of two new vaccines from Glaxosmithkline and a timeline for the company's large phase III test of a vaccine against airway virus RSV.
The timeline for the RSV vaccine has been particularly long-awaited, as Bavarian's negotiations with the American medicine authorities over the design of the study have dragged out, and the final agreement has come much later than expected.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Genmab to submit cancer candidate epcoritamab to the FDA before year-end
The US Food and Drug Administration will receive a marketing authorization application from Genmab and its partner Abbvie in the second half of this year.
Bavarian Nordic is working with EMA on monkeypox vaccine label expansion
Bavarian Nordic’s smallpox vaccine Imvanex has previously been used off-label to protect close contacts from monkeypox in several countries. The Danish vaccine firm is now working with the EMA to expand the label in an ”accelerated process.”
Leo Pharma eczema treatment recommended in two UK countries
After postponing the decision in April, the British medicines council NICE has now ruled that Adtralza can be recommended to treat atopic dermatitis.
Fujifilm invests USD 1.5bn in Danish factory
Japanese firm Fujifilm Diosynth Biotechnologies is investing DKK 11bn (USD 1.5bn) in its factor in Northern Zealand, Denmark. The expansion will provide 450 jobs.
Life science firms are planning USD 6.3bn construction spree in Denmark
Fujifilm’s expansion to its factory in Hillerød means that the life science sector has announced DKK 12bn (USD 1.7bn) in facility investments in Denmark since May.
Device Associate Director/Senior Project Leader 
(Sr) Clinical Trial Manager 
Specialist within Project Management and Launch, Regulatory Affairs Life Cycle Management 
KLIFO is looking for a Project Director for our office in Denmark or Germany or Sweden 
QA Specialist for Product Equipment Qualification 
Biomarker Operations Lead 
Nordic Medical Advisor 
Principal Laboratory Technologist Medicinal Chemistry 
Global Learning Specialist 
Senior Manager/Associate Director, Global Regulatory Affairs, CMC 
Director Regulatory Affairs